You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prediction of treatment response

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Deep Learning Model for the Prediction of Post-LT HCC Recurrence

Completed
  • Liver Transplant Disorder
  • +2 more
  • Liver transplantation
  • Rome, RM, Italy
    Quirino Lai
Jun 27, 2022

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma Trial in Lyon (radiation, other, procedure)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Neoadjuvant RT
  • +3 more
  • Lyon, Rhône, France
    Centre Léon Bérard
Jan 12, 2023

Rheumatoid Arthritis Trial in Palmetto Bay, Lincoln, Duncansville (TC99m-tilmanocept)

Recruiting
  • Rheumatoid Arthritis
  • Palmetto Bay, Florida
  • +2 more
May 9, 2022

Inflammatory Response Trial in College Station (Pneumovax 23, Typhim VI, Saline)

Recruiting
  • Inflammatory Response
  • Pneumovax 23
  • +2 more
  • College Station, Texas
    Texas A&M University - CTRAL
Apr 19, 2022

Hepatocellular Carcinoma Trial in Seoul (MRI)

Recruiting
  • Hepatocellular Carcinoma
  • MRI
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Dec 16, 2021

tDCS Response Prediction Using EEG in Stroke

Recruiting
  • Stroke
  • +3 more
  • Cathodal transcranial direct current stimulation (tDCS) over the contralesional motor cortex
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
May 15, 2022

Metastatic Breast Cancer, Recurrent Ovarian Carcinoma Trial in Salt Lake City, Fairfax (Ribociclib, Belinostat)

Recruiting
  • Metastatic Breast Cancer
  • Recurrent Ovarian Carcinoma
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Pain Phenotyping in Knee OA: a Pilot Trial

Recruiting
  • Observational Study; Association of Patient Pain Characteristics and Total Knee Arthroplasty Response
  • n/a, observational
  • Hamilton, Ontario, Canada
  • +1 more
Sep 27, 2023

Response in Monosymptomatic Nocturnal Enuresis (MEN).

Completed
  • Nocturnal Enuresis
  • blood sampling
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel
Dec 10, 2021

Burning Mouth Syndrome Trial in Napoli (Vortioxetine 20Mg Tab, Paroxetine 20 Mg Oral Tablet, Sertraline 50 MG)

Recruiting
  • Burning Mouth Syndrome
  • Vortioxetine 20Mg Tab
  • +6 more
  • Napoli, Italia, Italy
    University of Naples Federico II
Aug 29, 2023

Early Predict Pathological Complete Response to Neoadjuvant

Recruiting
  • Breast Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Aug 8, 2022

    Breast Tumors Trial in Shanghai (Neoadjuvant radiotherapy)

    Recruiting
    • Breast Neoplasms
    • Neoadjuvant radiotherapy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 28, 2022

    Biomarkers for Prediction of Tumor Response to Radiotherapy

    Recruiting
    • Solid Tumors
      • Shantou, Guangdong, China
        Cancer Hospital, Shantou University Medical College
      Dec 27, 2021

      Neoadjuvant Radiation Chemotherapy Through Texture Analysis

      Completed
      • Rectal Cancer
        • Quimper, Bretagne, France
        • +2 more
        Nov 23, 2021

        Ulcerative Colitis Trial in Seoul (Vedolizumab, Ustekinumab, or Tofacitinib)

        Recruiting
        • Ulcerative Colitis
        • Vedolizumab, Ustekinumab, or Tofacitinib
        • Seoul, Korea, Republic of
          Asan Medical Center
        Feb 14, 2022

        Depressive Disorder, Major Trial in France (Digital Assessment on mobile)

        Recruiting
        • Depressive Disorder, Major
        • Digital Assessment on mobile
        • Cholet, France
        • +11 more
        Mar 17, 2022

        Cell-free DNA Methylation Markers for Hepatocellular Carcinoma

        Recruiting
        • Cell-free Methylation Markers
          • Taipei, Taiwan, Taiwan
            National Taiwan University Hospital
          Oct 6, 2022

          Pancreatic Cancer Trial in Salt Lake City (PET/CT scan to assess treatment efficacy)

          Completed
          Has Results
          • Pancreatic Cancer
          • PET/CT scan to assess treatment efficacy
          • Salt Lake City, Utah
            Huntsman Cancer Institute
          Sep 21, 2021

          PRediction Of Glycemic RESponse Study

          Recruiting
          • Glycemic Response
          • Continuous glucose monitoring
          • San Diego, California
            Scripps Research Translational Institute
          Jul 12, 2021

          Pharmacogenetic Testing and Chronic Pain

          Not yet recruiting
          • Chronic Pain
          • Genetic test for drug response prediction
          • Ottawa, Ontario, Canada
            Canadian Forces Health Services Centre
          Apr 28, 2022

          Lung Cancer Trial in Angers, St Herblain (Metastasis biopsy)

          Not yet recruiting
          • Lung Cancer
          • Metastasis biopsy
          • Angers, France
          • +1 more
          Jul 26, 2022

          Intrahepatic Cholangiocarcinoma Trial in Philadelphia (Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound)

          Recruiting
          • Intrahepatic Cholangiocarcinoma
          • Perflutren Protein-Type A Microspheres
          • Contrast-Enhanced Ultrasound
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Apr 7, 2022

          Esophageal Cancer Trial in Daegu (chemoradiotherapy)

          Recruiting
          • Esophageal Cancer
          • chemoradiotherapy
          • Daegu, Korea, Republic of
            Kyungpook National University Medical Canter
          Aug 8, 2021

          d to Predict Intra-arterial Chemotherapy Response in

          Recruiting
          • Retinoblastoma
          • Dynamic contrast-enhanced MRI
          • Paris, France
            Fondation A De Rothschild
          Mar 18, 2022